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Coronavirus disease 2019 (COVID‐19) has had an unprecedented
impact on the provision of healthcare services worldwide. The novel
severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) was
first declared by the World Health Organization as a global pandemic
on 11th March 2020.1 To date COVID‐19 has affected over 190
countries, with over 19 million confirmed cases and 710,000 asso-
ciated deaths,2 vastly increasing the global strain on healthcare
services and significantly impacting all elective surgeries. The natural
history of cardiac surgical disease, however, has required judicious
management of these high‐risk patients. Given the reliance of cardiac
surgery on extensive peri‐ and postoperative resources including
anesthetic and intensive care staff, blood products and ventilators;
the need to triage and manage resources, when these facilities are
scarce, is imperative.3,4 This has created a global necessity for cardiac
surgery programs to adapt during such pandemic.
While a wealth of research has been published evaluating
adaptations within the developed countries, comparatively little has
been published outlining the provision of services in developing
countries.4‐6 These shortcomings are highly significant given that, in
such countries, barriers to surgical care and disease burden vary
greatly in comparison.7,8 Ramsingh et al reported their experience of
58 patients who had undergone cardiac surgery in two centers be-
tween April and June 2020. Three of those patients were acute aortic
dissections while the rest were combination of urgent coronary
artery bypass grafting and/or symptomatic aortic valve replacements.
Patient selection was identified through multidisciplinary team
(MDT) discussions and surgery planned accordingly.9 Operations on
these patients was carried out using personal protective equipment
(PPE) and minimising theatre staff to the lowest safe possible num-
bers. Their experience reflects how cardiac surgery has been adapted
safely in the high‐income developing country of Trinidad and Tobago
(T&T) during these unprecedented times.9 While T&T have the sec-
ond highest income per capita in the region, national health in-
dicators significantly lag behind economic growth and substantial
pockets of poverty remain.10 Despite its small population of 1.40
million, T&T has the world's 34th highest population density, similar
to that of the United States of America. It has had, nonetheless,
remarkably low COVID‐19 cases (142 cases per one million popu-
lation, perhaps reflecting a low testing rate) and low associated
deaths (eight deaths in total).The twin island state therefore provides
a unique opportunity to examine successful strategies to safely de-
liver cardiac surgery in a developing country.11,12 These changes may
subsequently be compared with low‐ and middle‐income countries
(LMICs), in addition to their developed counterparts.
Like many countries across the globe, the burden on healthcare
services resulted in the suspension of all elective surgeries in T&T.9,13
Their deferral proves to be an important step in enabling the
reallocation of limited staff to intensive care units (ICUs) and
rationing the use of supplies including PPE and blood products. The
introduction of aggressive healthcare policies was deemed essential
to reduce the risk of transmission and likelihood of patients acquiring
nosocomial COVID‐19 infection. Such precautions stem from the fact
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that patients with pre‐existing cardiovascular disease are more likely
to have unfavorable clinical outcomes with COVID‐19 infection.14
In T&T, these aggressive policies took the form of a mass re-
structuring of healthcare into “parallel systems”with “hot” (COVID‐19
presumed or proven) and “cold” (COVID‐19 negative) centers.9 While
such a strategy has been possible in high‐income countries, limited
accessibility and border closures in LMICs meant many were forced to
rely on a single center to cope with a surge in COVID‐19 infections.
The redistribution of resources within these centers reduced cardiac
surgical services to a bare minimum.15 This was exacerbated by the
disruption of conventional supply chains and surgical donations to
LMICs following border closures and travel restrictions.7
Within developed countries, health demographics and COVID‐19
related burden were also key influencers of resource management
and allocation. In National Health Service (NHS) England, a protocol
known as Pan‐London Emergency Cardiac surgery (PLECS) was de-
signed to permit cardiac surgery for urgent and emergency cases.
From a total of seven cardiac centers based in London, two were
selected as central hubs, with access to their Accident and Emer-
gency departments suspended to maintain a COVID‐19 free
environment.16 Healthcare systems within the United States of
America adopted a similar approach.17 Meanwhile, in Canada, a
three‐stage system with a variable degree of service reduction was
implemented.18 In developed countries with extensive viral spread, a
“hub‐and‐spoke” model was preferred for delivering cardiac surgery.
This entailed a select number of tertiary centers being assigned as
restricted‐access cold operating centers (Hubs), and a majority of
other cardiovascular centers were open‐access hot referring units
with surgery suspended, termed spokes. Hubs focused on the pro-
vision of emergency cardiac surgery, whilst spokes concentrated on
patient enrollment.19 This strategy was convenient to re‐distribute
critical resources for COVID‐19 patients.
Canceling elective surgery has also provided a new challenge for a
multitude of cardiac surgical teams. There has been a need to differ-
entiate between patients requiring urgent care and those for whom
surgery can be safely postponed.3 Risks of deferring surgery include
worsening of the patient's condition, which may subsequently com-
promise their fitness for later procedures. To make this distinction,
international cardiac services were required to triage and prioritise
their patients. A notable difference between T&T and other HICs, was
the use of telemedicine. An important aspect of telehealth in cardiac
surgery was tele‐triage, allowing for the risk stratification of
patients.20 Within PLECS, patients were categorised into four levels
based on their urgency. Elective patients were classified as level 1;
level 2 consisted of patients at home in need of urgent care; inpatients
occupied level 3 and level 4 were emergency cases requiring urgent
surgery.16 While telecardiology has been recommended by the
American College of Surgery, T&T continued to triage utilising MDT
(cardiac surgical teams) in preoperative clinics, with enforced social
distancing measures.9 Assuming that the 58 patients operated on
during the two‐month study period were distributed evenly, this is a
manageable footfall for a department, however this model is unlikely
to have been possible in services with larger caseloads.
In addition to difficulties with surgical triage, there is concern
over the backlog of cases that canceling or postponing elective sur-
gical procedures has created. There is an estimated worldwide
backlog of nearly 30 million elective procedures in just 12 weeks.13 In
LMICs, where surgical delivery is already constrained, the pandemic
may have even greater consequences.8 The scale of the repercus-
sions has been felt globally with even well‐resourced surgical
healthcare systems, such as the NHS in UK and North American
health care systems struggling to cope with the ever‐increasing
demands of this backlog.
There are some parallels between the management of patients
requiring cardiac surgery in developed and developing countries.
Measures, such as social distancing, use of PPE, enhanced precau-
tions for aerosol generating procedures (AGPs) and quarantine have
been universally adopted. Other measures, such as reverse tran-
scriptase polymerase chain reaction (RT‐PCR) testing of prospective
patients have been resource dependent.22 T&T have performed 9390
COVID tests during this pandemic. By comparison a third of this
number were performed by the authors' (AAH/BHK) single tertiary
level hospital in the United Kingdom. The extent of the availability of
this testing depends on many factors, including access to financial
resources within healthcare services. While private hospitals in T&T
are able to provide preoperative RT‐PCR testing for all patients, this
is not the case for public healthcare services. A limited availability of
tests resulted in only symptomatic cardiac surgical patients received
preoperative RT‐PCR.9 Given that 43% to 60% of patients with
COVID‐19 are thought to be asymptomatic, this has implications for
risk stratification and preventing disease spread.3,23,24 Therefore,
testing for SARS‐CoV‐2 in patients undergoing cardiac surgery is
important as many of such patients are asymptomatic and may have
subclinical infections which could have significant impact on peri‐
operative outcomes.25
An international cohort study, including 1128 patients, organised
by COVIDSurg Collaborative, report a 23.8% postoperative 30‐day
mortality (n = 268) in patients infected with SARS‐CoV‐2.26 In addi-
tion to an increase in overall mortality, the use of cardiopulmonary
bypass (CPB) in patients with COVID‐19 is thought to increase the
risk of acute respiratory distress syndrome (ARDS). It is hypothesised
that exposure of blood to non‐endothelial surfaces during CPB trig-
gers a proinflammatory response, increasing both tumor necrosis
factor α and interleukin 10,16 two cytokines implicated in ARDS in
COVID‐19.3,27
Given the associated risks and frequency of AGPs involved in
cardiac surgery, preoperative testing plays a significant role in re-
source allocations. Thus, in developing countries, where testing may
be restricted, the authors demonstrate the two different approaches
to dealing with this conundrum. In the private sector, they demon-
strated the use of prioritising tests to high risk groups (those un-
dergoing cardiac surgery) and in the state hospitals ensuring that all
other preventative measures were executed rigorously. One possible
method to do so is by implementing a preoperative testing algorithm,
such as one recommended by Patel et al,3 based on patients' travel,
exposure history and community prevalence. This is perhaps a more
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reliable method than symptom manifestation. Such testing mechan-
ism should be complemented by strict preoperative shielding mea-
sures, the likes of which have already been implemented within T&T.9
Surgical equipment and SARS‐CoV‐2 testing have not been the
only global scarcity during this pandemic. Blood transfusions have
also been restricted due to a limited number of blood donations,
secondary to national and regional lockdowns. Such issues have been
reported by Ramsingh et al to have particularly affected T&T causing
a national shortage.9 They were able to mitigate for this by utilising
off‐pump coronary surgery and use of autologous blood transfusion.
It is not only limitations of tangible resources, including venti-
lators and PPE, that provide restrictions on the provision of cardiac
surgery. During COVID‐19, many healthcare systems reallocated
surgical staff to the emergency frontline and ICUs to overcome the
burden of the pandemic.4,8,29 Although Ramsingh et al reported that
many countries, such as UK, Italy, and Canada have practiced the
redeployment of cardiac surgical staff to general critical care areas to
facilitate ventilated patients with COVID, their own staff redeploy-
ment remains unclear. The mandatory 2‐week isolation of cardiac
surgical staff outside of work was an additional precaution made in
T&T that was particularly patient‐centric. Such requirements of
healthcare workers would probably not be feasible in developed
countries but were implemented in T&T to compensate for the re-
duced levels of testing. Before the pandemic, the Lancet Commission
on Global Surgery estimated a need of 20 surgeons, anaesthesiolo-
gists and obstetricians per 100,000 population for LMICs to meet the
burden of surgical disease. Yet, statistics show LMIC only met half of
this recommendation.30 This shortage may only be compounded by
deficiencies in PPE, staff burn‐out and inevitable exposure of health
care workers to SARS‐CoV‐2.8
The impact of COVID‐19 has been felt throughout healthcare
systems across the globe, indiscriminately affecting developed and
developing nations.31 In many specialties including cardiac surgery,
caution and improvisation has been essential to continue provide
services to those in whom the risks of the natural history of their
disease outweigh those of the risks of catching COVID‐19 in hospital.32
This is particularly true of cardiac surgical disease. Between the 190
countries that have been affected by COVID‐19, each nation's acces-
sibility to such resources vary widely. Ramsingh et al demonstrate well
that basic measures, such as social distancing, mandatory preoperative
isolation and rigorous PPE can supplement and mitigate for reduced
access to swab testing. They demonstrate well that there is no uni-
versally applicable worldwide framework for the provision of cardiac
surgery during the pandemic. Individual nations' responses to the
pandemic must consider their service burden and availability of re-
sources, including staff and undertake appropriate surgical prioritiza-
tion, triage and preoperative assessment. It appears to be possible to
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